Noked Israel LTD Xtl Biopharmaceuticals LTD Transaction History

Noked Israel LTD

  • $458 Million
  • Q3 2024

A detailed history of Noked Israel LTD transactions in Xtl Biopharmaceuticals LTD stock. As of the latest transaction made, Noked Israel LTD holds 198,888 shares of XTLB stock, worth $338,109. This represents 0.1% of its overall portfolio holdings.

Number of Shares
198,888
Previous 198,888 -0.0%
Holding current value
$338,109
Previous $483,000 1.24%
% of portfolio
0.1%
Previous 0.13%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 14, 2019
SELL
$1.44 - $2.1 $1 - $2
-1 Reduced -0.0%
198,888 $286,000
Q4 2018

Feb 13, 2019
BUY
$1.43 - $2.98 $284,411 - $592,689
198,889 New
198,889 $344,000

Others Institutions Holding XTLB

# of Institutions
5
Shares Held
431K
Call Options Held
0
Put Options Held
0
View Full List

About XTL BIOPHARMACEUTICALS LTD

XTLB Quotes by TradingView
  • Ticker XTLB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 5,449,060
  • Market Cap $9.26M
  • Description
  • XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical products for the treatment of autoimmune diseases. The company's lead drug candidate is hCDR1, a Phase II-ready asset for the treatment of systemic lupus erythematosus and Sjogren's syndrome. It has a licensing agreement with Ye...
More about XTLB
Track This Portfolio

Track Noked Israel LTD Portfolio

Follow Noked Israel LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Noked Israel LTD, based on Form 13F filings with the SEC.

News

Stay updated on Noked Israel LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email